35753845 35328748 33922585 34127518 35286658 32803224 30928868 32858428 32912327 32203525 32299494 35672656 31396533 30743990 35979366 30948723 32187546 36012501 30852796 34396107 30806312 34033211 34761292 33324164 31349874 - Search Results

Year	Number of Results
2019	7
2020	7
2021	4
2022	7
2023	0

1

Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions.

Squillace S, Salvemini D. Squillace S, et al. Trends Pharmacol Sci. 2022 Sep;43(9):726-739. doi: 10.1016/j.tips.2022.05.004. Epub 2022 Jun 23. Trends Pharmacol Sci. 2022. PMID: 35753845 Review.

2

Intracerebral but Not Peripheral Infection of Live Porphyromonas gingivalis Exacerbates Alzheimer's Disease Like Amyloid Pathology in APP-TgCRND8 Mice.

Aravindraja C, Sakthivel R, Liu X, Goodwin M, Veena P, Godovikova V, Fenno JC, Levites Y, Golde TE, Kesavalu L. Aravindraja C, et al. Int J Mol Sci. 2022 Mar 19;23(6):3328. doi: 10.3390/ijms23063328. Int J Mol Sci. 2022. PMID: 35328748 Free PMC article.

3

Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.

Mahjoubin-Tehran M, Teng Y, Jalili A, Aghaee-Bakhtiari SH, Markin AM, Sahebkar A. Mahjoubin-Tehran M, et al. Int J Mol Sci. 2021 Apr 23;22(9):4420. doi: 10.3390/ijms22094420. Int J Mol Sci. 2021. PMID: 33922585 Free PMC article. Review.

4

Microglia show differential transcriptomic response to Aβ peptide aggregates ex vivo and in vivo.

McFarland KN, Ceballos C, Rosario A, Ladd T, Moore B, Golde G, Wang X, Allen M, Ertekin-Taner N, Funk CC, Robinson M, Baloni P, Rappaport N, Chakrabarty P, Golde TE. McFarland KN, et al. Life Sci Alliance. 2021 Jun 14;4(7):e202101108. doi: 10.26508/lsa.202101108. Print 2021 Jul. Life Sci Alliance. 2021. PMID: 34127518 Free PMC article.

5

Microglia in Alzheimer's Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis.

McFarland KN, Chakrabarty P. McFarland KN, et al. Neurotherapeutics. 2022 Jan;19(1):186-208. doi: 10.1007/s13311-021-01179-3. Epub 2022 Mar 14. Neurotherapeutics. 2022. PMID: 35286658 Free PMC article. Review.

6

Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.

Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, Volak A, LeRoy S, Gandhi S, Lerner EP, Hudry E, Tanzi RE, Maguire CA. Griciuc A, et al. Hum Mol Genet. 2020 Oct 10;29(17):2920-2935. doi: 10.1093/hmg/ddaa179. Hum Mol Genet. 2020. PMID: 32803224 Free PMC article.

7

Toll-like receptors in the pathogenesis of neuroinflammation.

Kumar V. Kumar V. J Neuroimmunol. 2019 Jul 15;332:16-30. doi: 10.1016/j.jneuroim.2019.03.012. Epub 2019 Mar 20. J Neuroimmunol. 2019. PMID: 30928868 Review.

8

Toll-like receptors in Alzheimer's disease.

Momtazmanesh S, Perry G, Rezaei N. Momtazmanesh S, et al. J Neuroimmunol. 2020 Nov 15;348:577362. doi: 10.1016/j.jneuroim.2020.577362. Epub 2020 Aug 19. J Neuroimmunol. 2020. PMID: 32858428 Review.

9

Activation of Toll-like receptor 5 in microglia modulates their function and triggers neuronal injury.

Ifuku M, Hinkelmann L, Kuhrt LD, Efe IE, Kumbol V, Buonfiglioli A, Krüger C, Jordan P, Fulde M, Noda M, Kettenmann H, Lehnardt S. Ifuku M, et al. Acta Neuropathol Commun. 2020 Sep 10;8(1):159. doi: 10.1186/s40478-020-01031-3. Acta Neuropathol Commun. 2020. PMID: 32912327 Free PMC article.

10

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.

Zhou M, Xu R, Kaelber DC, Gurney ME. Zhou M, et al. PLoS One. 2020 Mar 23;15(3):e0229819. doi: 10.1371/journal.pone.0229819. eCollection 2020. PLoS One. 2020. PMID: 32203525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results